Artwork

Kandungan disediakan oleh Nate Bergman and Evolving Past Alzheimer's. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Nate Bergman and Evolving Past Alzheimer's atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !

Why I'm excited about Aducanumab (Aduhelm)!

11:58
 
Kongsi
 

Manage episode 298622275 series 1910375
Kandungan disediakan oleh Nate Bergman and Evolving Past Alzheimer's. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Nate Bergman and Evolving Past Alzheimer's atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Dr. Nate Bergman quickly summarizes the story up the FDA's recent "accelerated approval" of Biogen's - Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval...and it's probably not what you think! A quick, but useful listen.

In this episode we talk about…

  • The terms of the approval of the drug
  • What Aducanumab was able to accomplish in Alzheimer's patients
  • The circumstances that led to Aducanumab being approved
  • Some of the problems that arise with Aducanumab
  • Why I am excited about Aducanumab
  continue reading

77 episod

Artwork
iconKongsi
 
Manage episode 298622275 series 1910375
Kandungan disediakan oleh Nate Bergman and Evolving Past Alzheimer's. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Nate Bergman and Evolving Past Alzheimer's atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.

Dr. Nate Bergman quickly summarizes the story up the FDA's recent "accelerated approval" of Biogen's - Aducanumab (brand named, Aduhelm). He ends off with surprise about why he is excited about the approval...and it's probably not what you think! A quick, but useful listen.

In this episode we talk about…

  • The terms of the approval of the drug
  • What Aducanumab was able to accomplish in Alzheimer's patients
  • The circumstances that led to Aducanumab being approved
  • Some of the problems that arise with Aducanumab
  • Why I am excited about Aducanumab
  continue reading

77 episod

Όλα τα επεισόδια

×
 
Loading …

Selamat datang ke Player FM

Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.

 

Panduan Rujukan Pantas

Podcast Teratas